Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-23

Clinical Trial Update: Comparison of Mineral Trioxide Aggregate (MTA) and 20% Formocresol (FC) in Pulpotomized Human Primary Molars [NA]

View source ↗

Summary

This study compares Mineral Trioxide Aggregate (MTA) with 20% formocresol for pulpotomy in human primary molars; the trial status is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Formocresol (Formocresol)
  • Mineral Trioxide Aggregate (mineral trioxide aggregate)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Dental Caries, Pulpitis | NA | Status: UNKNOWN